Clinical Trials Browser

OTHER × Ashwagandha × Clear all

NCT04092647 2023-06-15

Ashwagandha for Cognitive Dysfunction

Phase 2 Unknown

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction

NCT00817752 2010-03-18

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

Phase 1 Completed

Autoimmune Diseases, Inflammation, Neoplasms